A look at on-demand medical startups in the US like Heal and The I.V Doc, which are helping users get treatment for nonemergency problems at home or work
Businesses can deliver everything on demand, from dinner to dry cleaning. Some will even show up at your door to give you cupcakes or walk your dog.
Context & Ripple Effects
Heal and The I.V. Doc are applying the on-demand playbook to medicine: instead of patients traveling to clinics, clinicians travel to them for nonemergency problems at home or work. They arrived alongside a broader wave of venture-backed care delivery — an overview of US telemedicine startups from urgent care to fertility shows significant capital flowing into the category around the same time.
The competitive set splits by channel: where Heal dispatches people, rivals like CirrusMD and 98point6 let users reach doctors over text-based online chats for minor injuries and illnesses — a structurally cheaper way to deliver the same low-acuity visit. And the logistics-heavy end of on-demand has since produced a cautionary tale, with [[a:980865|rapid delivery startups retreating or shutting down after struggling to make the economics work]].
First-order effects
- Patients with nonemergency conditions gain a same-day alternative to clinic waiting rooms, while Heal and The I.V. Doc take on the full cost of clinician travel time per visit rather than batching patients at a fixed site.
- Text-first telemedicine players like CirrusMD and 98point6 now compete against a premium house-call format for the same low-acuity cases, putting pressure on the per-visit price a patient or payer will accept.
Second-order effects
- Ride-hailing platforms are moving into the adjacent logistics layer: Lyft and Uber's entry into the estimated $3B non-emergency medical transportation business positions everyday drivers to handle the patient-movement side of care that house-call startups internalize.
- If per-visit dispatch costs mirror what sank rapid grocery and meal delivery — where VC-backed firms raised heavily before retreating — insurers and employers will favor chat-based and transport-bundled models over owned fleets of traveling clinicians.
Third-order effects
- Low-acuity care is likely to stratify by cost channel: text chats as the default, dispatched house calls as a paid premium tier, and rides as commodity infrastructure — pushing house-call startups to prove unit economics or cede the volume to remote-first rivals.
- As more care moves out of clinics, reimbursement and regulation become the structural battleground: payers deciding which on-demand formats they cover will effectively pick which delivery models survive, a question still unresolved across telemedicine broadly.
The trend: US healthcare delivery is unbundling the clinic visit into competing on-demand channels — house calls, text chats, and patient transport — with unit economics and payer coverage deciding which format wins each tier of low-acuity care.